Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9


Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML.

Björklund AT, Carlsten M, Sohlberg E, Liu LL, Clancy T, Karimi M, Cooley S, Miller JS, Klimkowska M, Schaffer M, Watz E, Wikström K, Blomberg P, Wahlin BE, Palma M, Hansson L, Ljungman P, Hellström-Lindberg E, Ljunggren HG, Malmberg KJ.

Clin Cancer Res. 2018 Feb 14. doi: 10.1158/1078-0432.CCR-17-3196. [Epub ahead of print]


Naive Donor NK Cell Repertoires Associated with Less Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.

Björklund AT, Clancy T, Goodridge JP, Béziat V, Schaffer M, Hovig E, Ljunggren HG, Ljungman PT, Malmberg KJ.

J Immunol. 2016 Feb 1;196(3):1400-11. doi: 10.4049/jimmunol.1501434. Epub 2016 Jan 8.


Harnessing adaptive natural killer cells in cancer immunotherapy.

Liu LL, Pfefferle A, Yi Sheng VO, Björklund AT, Béziat V, Goodridge JP, Malmberg KJ.

Mol Oncol. 2015 Dec;9(10):1904-17. doi: 10.1016/j.molonc.2015.10.001. Epub 2015 Oct 20. Review.


Therapeutic potential and challenges of natural killer cells in treatment of solid tumors.

Gras Navarro A, Björklund AT, Chekenya M.

Front Immunol. 2015 Apr 29;6:202. doi: 10.3389/fimmu.2015.00202. eCollection 2015. Review.


Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease.

Munneke JM, Björklund AT, Mjösberg JM, Garming-Legert K, Bernink JH, Blom B, Huisman C, van Oers MH, Spits H, Malmberg KJ, Hazenberg MD.

Blood. 2014 Jul 31;124(5):812-21. doi: 10.1182/blood-2013-11-536888. Epub 2014 May 22.


NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs.

Béziat V, Liu LL, Malmberg JA, Ivarsson MA, Sohlberg E, Björklund AT, Retière C, Sverremark-Ekström E, Traherne J, Ljungman P, Schaffer M, Price DA, Trowsdale J, Michaëlsson J, Ljunggren HG, Malmberg KJ.

Blood. 2013 Apr 4;121(14):2678-88. doi: 10.1182/blood-2012-10-459545. Epub 2013 Jan 16.


Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education.

Björkström NK, Riese P, Heuts F, Andersson S, Fauriat C, Ivarsson MA, Björklund AT, Flodström-Tullberg M, Michaëlsson J, Rottenberg ME, Guzmán CA, Ljunggren HG, Malmberg KJ.

Blood. 2010 Nov 11;116(19):3853-64. doi: 10.1182/blood-2010-04-281675. Epub 2010 Aug 9.


NK cells expressing inhibitory KIR for non-self-ligands remain tolerant in HLA-matched sibling stem cell transplantation.

Björklund AT, Schaffer M, Fauriat C, Ringdén O, Remberger M, Hammarstedt C, Barrett AJ, Ljungman P, Ljunggren HG, Malmberg KJ.

Blood. 2010 Apr 1;115(13):2686-94. doi: 10.1182/blood-2009-07-229740. Epub 2010 Jan 22.


Estimation of the size of the alloreactive NK cell repertoire: studies in individuals homozygous for the group A KIR haplotype.

Fauriat C, Andersson S, Björklund AT, Carlsten M, Schaffer M, Björkström NK, Baumann BC, Michaëlsson J, Ljunggren HG, Malmberg KJ.

J Immunol. 2008 Nov 1;181(9):6010-9.

Supplemental Content

Loading ...
Support Center